40.60
-0.26
(-0.64%)
At close: 3:29:41 PM GMT+5:30
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Ranjan Jain | MD & Director | -- | -- | 1966 |
| Mr. Sanjeev Agrawal | Chief Financial Officer | -- | -- | -- |
| Ms. Shikha Kataria B.Com., C.S., L.L.B. | Company Secretary & Compliance Officer | -- | -- | -- |
| Mr. Suninder Veer Singh | Whole-Time Director | -- | -- | 1974 |
Syschem (India) Limited
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 105
Description
Syschem (India) Limited manufactures and sells active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. The company's APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. It also engages in the distillation of specialty solvents, such as DMF, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and is based in Chandigarh, India.
Corporate Governance
Syschem (India) Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 4, 2025 at 9:10 AM UTC
Syschem (India) Limited Earnings Date
Recent Events
Recent Events Information Not Available